Finance

Lists
CRMD:NASDAQ
CorMedix Inc
$7.38
+1.65%
(+0.12) 1D
$7.40
+0.27% (+0.020)
After hours
Closed: Oct 19, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for CRMD...
Open
$7.26
High
$7.57
Low
$7.25
Mkt. cap
575.23M
Avg. vol.
972.41K
Volume
0.00
P/E ratio
3.46
52-wk high
$13.02
52-wk low
$6.12
EPS
$2.13
Beta
1.40
Shares outstanding
77.94M
No. of employees
191
Open
$7.26
High
$7.57
Low
$7.25
Mkt. cap
575.23M
Avg. vol.
972.41K
Volume
0.00
P/E ratio
3.46
52-wk high
$13.02
52-wk low
$6.12
EPS
$2.13
Beta
1.40
Shares outstanding
77.94M
No. of employees
191
News stories
From web sources and news partners
About CorMedix Inc
CEO-
Employees191
Founded2006
HeadquartersBerkeley Heights, New Jersey, United States
SectorPharmaceutical industry
Websitecormedix.com
Analyst ratings
Based on 4 analysts giving stock ratings to CRMD in the past 3 months
Strong buy
Buy
4
Hold
0
Sell
0
12-month forecast
Based on 4 Wall Street analysts offering 12 month price targets for CRMD in the last 3 months.
Highest
Current $7.38
$15.00 (+103.25%)
Average
$14.25 (+93.09%)
Lowest
$13.00 (+76.15%)
Analyst
Recommendation
Action
Price target
Projected
Date
Leonid Timashev
RBC Capital
Buy
Maintained
$14.00
+89.7%
10/08/2026
Unknown Analyst
Oppenheimer
Buy
Initiated
$15.00
+103.3%
09/23/2026
Brandon Folkes
H.C. Wainwright
Buy
Reiterated
$13.00
+76.2%
08/14/2026
Serge Belanger
Needham
Buy
Maintained
$15.00
+103.3%
08/13/2026
Roanna Ruiz
Leerink Partners
Buy
Reiterated
$15.00
+103.3%
05/15/2026
Les Sulewski
Truist Financial
Buy
Maintained
-
-
05/15/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
104.28M
128.62M
127.43M
101.93M
Cost of goods sold
7.57M
11.17M
12.00M
14.50M
Cost of revenue
7.57M
11.17M
12.00M
14.50M
Research and development expenses
5.10M
8.60M
7.21M
6.68M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
36.64M
29.38M
34.25M
27.53M
Operating expense
45.36M
48.12M
51.76M
44.52M
Total operating expenses
52.93M
59.29M
63.77M
59.02M
Operating income
51.35M
69.33M
63.66M
42.91M
Other non operating income
-
-
-268.00K
-71.00K
EBT including unusual items
52.58M
56.45M
55.64M
38.73M
EBT excluding unusual items
51.89M
68.47M
63.39M
42.84M
Income tax expense
-55.99M
42.43M
17.04M
12.74M
Effective tax rate
-106.49%
75.16%
30.63%
32.90%
Other operating expenses
-
-
-
-
Net income
108.56M
14.02M
38.60M
25.99M
Net profit margin
104.11%
10.90%
30.29%
25.50%
Earnings per share
1.41
0.16
0.35
-
Interest and investment income
1.56M
889.98K
-
-
Interest expense
-948.24K
-1.82M
-
-
Net interest expenses
612.03K
-927.10K
-
-
Depreciation and amortization charges
-
-
-
-
EBITDA
55.14M
79.76M
74.20M
53.45M
Gain or loss from assets sale
-
-86.00K
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps